n-acetylneuraminic acid has been researched along with rosiglitazone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bashir, M; Iqbal, M; Khan, R; Malik, SA | 1 |
| Bashir, M; Idrees, M; Khan, RU; Malik, SA; Rahman, IU | 1 |
| Amin, F; Idrees, M; Jan, NU; Khan, MI; Khan, RU; Salman, M; ur Rahman, I | 1 |
2 trial(s) available for n-acetylneuraminic acid and rosiglitazone
| Article | Year |
|---|---|
Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fruit; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Momordica charantia; N-Acetylneuraminic Acid; Phytotherapy; Plant Preparations; Rosiglitazone; Thiazolidinediones; Triglycerides | 2009 |
A comparison of the effect of glitazones on serum sialic acid in patients with type 2 diabetes.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; N-Acetylneuraminic Acid; Pioglitazone; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2012 |
1 other study(ies) available for n-acetylneuraminic acid and rosiglitazone
| Article | Year |
|---|---|
Serum sialic acid changes in type 2 diabetic patients on metformin or rosiglitazone treatment.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; N-Acetylneuraminic Acid; Risk; Risk Factors; Rosiglitazone; Thiazolidinediones; Triglycerides | 2010 |